Cargando…

Chronic Embryo‐Larval Exposure of Fathead Minnows to the Pharmaceutical Drug Metformin: Survival, Growth, and Microbiome Responses

Metformin is a glucose‐lowering drug commonly found in municipal wastewater effluents (MWWEs). The present study investigated the chronic effects of metformin in early‐life stages of the fathead minnow (Pimephales promelas). Endpoints assessed were growth, survival, and deformities. The larval gut m...

Descripción completa

Detalles Bibliográficos
Autores principales: Parrott, Joanne L., Restivo, Victoria E., Kidd, Karen A., Zhu, Juliet, Shires, Kallie, Clarence, Stacey, Khan, Hufsa, Sullivan, Cheryl, Pacepavicius, Grazina, Alaee, Mehran
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9291798/
https://www.ncbi.nlm.nih.gov/pubmed/33788292
http://dx.doi.org/10.1002/etc.5054
_version_ 1784749216148488192
author Parrott, Joanne L.
Restivo, Victoria E.
Kidd, Karen A.
Zhu, Juliet
Shires, Kallie
Clarence, Stacey
Khan, Hufsa
Sullivan, Cheryl
Pacepavicius, Grazina
Alaee, Mehran
author_facet Parrott, Joanne L.
Restivo, Victoria E.
Kidd, Karen A.
Zhu, Juliet
Shires, Kallie
Clarence, Stacey
Khan, Hufsa
Sullivan, Cheryl
Pacepavicius, Grazina
Alaee, Mehran
author_sort Parrott, Joanne L.
collection PubMed
description Metformin is a glucose‐lowering drug commonly found in municipal wastewater effluents (MWWEs). The present study investigated the chronic effects of metformin in early‐life stages of the fathead minnow (Pimephales promelas). Endpoints assessed were growth, survival, and deformities. The larval gut microbiome was also examined using 16 S ribosomal RNA gene amplicon sequencing to determine microbial community composition and alpha and beta diversity. Eggs and larvae were exposed to metformin measured concentrations (mean [standard deviation]) of 0.020 (0.017) μg/L (for controls) and 3.44 (0.23), 33.6 (1.6), and 269 (11) μg/L in a daily static‐renewal setup, with 20 embryos per beaker. The low and middle metformin exposure concentrations represent river and MWWE concentrations of metformin. To detect small changes in growth, we used 18 replicate beakers for controls and 9 replicates for each metformin treatment. Over the 21‐d exposure (5 d as embryos and 16 d posthatch [dph]), metformin did not affect survival or growth of larval fish. Hatch success, time to hatch, deformities in hatched fry, and survival were similar across all treatments. Growth (wet wt, length, and condition factor) assessed at 9 and 16 dph was also unaffected by metformin. Assessment of the microbiome showed that the larvae microbiome was dominant in Proteobacteria and Firmicutes, with small increases in Proteobacteria and decreases in Firmicutes with increasing exposure to metformin. No treatment effects were found for microbiome diversity measures. Control fish euthanized with the anesthetic tricaine methane sulfonate had decreased alpha diversity compared to those sampled by spinal severance. This experiment demonstrates that metformin at environmentally relevant concentrations (3.44 and 33.6 μg/L) and at 10 times MWWE concentrations (269 µg/L) does not adversely affect larval growth or gut microbiome in this ubiquitous freshwater fish species. Environ Toxicol Chem 2022;41:635–647. © 2021 Her Majesty the Queen in Right of Canada. Environmental Toxicology and Chemistry published by Wiley Periodicals LLC on behalf of SETAC. Reproduced with the permission of the Minister of Environment and Climate Change Canada.
format Online
Article
Text
id pubmed-9291798
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-92917982022-07-20 Chronic Embryo‐Larval Exposure of Fathead Minnows to the Pharmaceutical Drug Metformin: Survival, Growth, and Microbiome Responses Parrott, Joanne L. Restivo, Victoria E. Kidd, Karen A. Zhu, Juliet Shires, Kallie Clarence, Stacey Khan, Hufsa Sullivan, Cheryl Pacepavicius, Grazina Alaee, Mehran Environ Toxicol Chem Special Section Metformin is a glucose‐lowering drug commonly found in municipal wastewater effluents (MWWEs). The present study investigated the chronic effects of metformin in early‐life stages of the fathead minnow (Pimephales promelas). Endpoints assessed were growth, survival, and deformities. The larval gut microbiome was also examined using 16 S ribosomal RNA gene amplicon sequencing to determine microbial community composition and alpha and beta diversity. Eggs and larvae were exposed to metformin measured concentrations (mean [standard deviation]) of 0.020 (0.017) μg/L (for controls) and 3.44 (0.23), 33.6 (1.6), and 269 (11) μg/L in a daily static‐renewal setup, with 20 embryos per beaker. The low and middle metformin exposure concentrations represent river and MWWE concentrations of metformin. To detect small changes in growth, we used 18 replicate beakers for controls and 9 replicates for each metformin treatment. Over the 21‐d exposure (5 d as embryos and 16 d posthatch [dph]), metformin did not affect survival or growth of larval fish. Hatch success, time to hatch, deformities in hatched fry, and survival were similar across all treatments. Growth (wet wt, length, and condition factor) assessed at 9 and 16 dph was also unaffected by metformin. Assessment of the microbiome showed that the larvae microbiome was dominant in Proteobacteria and Firmicutes, with small increases in Proteobacteria and decreases in Firmicutes with increasing exposure to metformin. No treatment effects were found for microbiome diversity measures. Control fish euthanized with the anesthetic tricaine methane sulfonate had decreased alpha diversity compared to those sampled by spinal severance. This experiment demonstrates that metformin at environmentally relevant concentrations (3.44 and 33.6 μg/L) and at 10 times MWWE concentrations (269 µg/L) does not adversely affect larval growth or gut microbiome in this ubiquitous freshwater fish species. Environ Toxicol Chem 2022;41:635–647. © 2021 Her Majesty the Queen in Right of Canada. Environmental Toxicology and Chemistry published by Wiley Periodicals LLC on behalf of SETAC. Reproduced with the permission of the Minister of Environment and Climate Change Canada. John Wiley and Sons Inc. 2021-06-02 2022-03 /pmc/articles/PMC9291798/ /pubmed/33788292 http://dx.doi.org/10.1002/etc.5054 Text en © 2021 Her Majesty the Queen in Right of Canada. Environmental Toxicology and Chemistry published by Wiley Periodicals LLC on behalf of SETAC. Reproduced with the permission of the Minister of Environment and Climate Change Canada. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
spellingShingle Special Section
Parrott, Joanne L.
Restivo, Victoria E.
Kidd, Karen A.
Zhu, Juliet
Shires, Kallie
Clarence, Stacey
Khan, Hufsa
Sullivan, Cheryl
Pacepavicius, Grazina
Alaee, Mehran
Chronic Embryo‐Larval Exposure of Fathead Minnows to the Pharmaceutical Drug Metformin: Survival, Growth, and Microbiome Responses
title Chronic Embryo‐Larval Exposure of Fathead Minnows to the Pharmaceutical Drug Metformin: Survival, Growth, and Microbiome Responses
title_full Chronic Embryo‐Larval Exposure of Fathead Minnows to the Pharmaceutical Drug Metformin: Survival, Growth, and Microbiome Responses
title_fullStr Chronic Embryo‐Larval Exposure of Fathead Minnows to the Pharmaceutical Drug Metformin: Survival, Growth, and Microbiome Responses
title_full_unstemmed Chronic Embryo‐Larval Exposure of Fathead Minnows to the Pharmaceutical Drug Metformin: Survival, Growth, and Microbiome Responses
title_short Chronic Embryo‐Larval Exposure of Fathead Minnows to the Pharmaceutical Drug Metformin: Survival, Growth, and Microbiome Responses
title_sort chronic embryo‐larval exposure of fathead minnows to the pharmaceutical drug metformin: survival, growth, and microbiome responses
topic Special Section
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9291798/
https://www.ncbi.nlm.nih.gov/pubmed/33788292
http://dx.doi.org/10.1002/etc.5054
work_keys_str_mv AT parrottjoannel chronicembryolarvalexposureoffatheadminnowstothepharmaceuticaldrugmetforminsurvivalgrowthandmicrobiomeresponses
AT restivovictoriae chronicembryolarvalexposureoffatheadminnowstothepharmaceuticaldrugmetforminsurvivalgrowthandmicrobiomeresponses
AT kiddkarena chronicembryolarvalexposureoffatheadminnowstothepharmaceuticaldrugmetforminsurvivalgrowthandmicrobiomeresponses
AT zhujuliet chronicembryolarvalexposureoffatheadminnowstothepharmaceuticaldrugmetforminsurvivalgrowthandmicrobiomeresponses
AT shireskallie chronicembryolarvalexposureoffatheadminnowstothepharmaceuticaldrugmetforminsurvivalgrowthandmicrobiomeresponses
AT clarencestacey chronicembryolarvalexposureoffatheadminnowstothepharmaceuticaldrugmetforminsurvivalgrowthandmicrobiomeresponses
AT khanhufsa chronicembryolarvalexposureoffatheadminnowstothepharmaceuticaldrugmetforminsurvivalgrowthandmicrobiomeresponses
AT sullivancheryl chronicembryolarvalexposureoffatheadminnowstothepharmaceuticaldrugmetforminsurvivalgrowthandmicrobiomeresponses
AT pacepaviciusgrazina chronicembryolarvalexposureoffatheadminnowstothepharmaceuticaldrugmetforminsurvivalgrowthandmicrobiomeresponses
AT alaeemehran chronicembryolarvalexposureoffatheadminnowstothepharmaceuticaldrugmetforminsurvivalgrowthandmicrobiomeresponses